Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GILD | VRTX | REGN | ||
| Company | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 89.07 | 454.24 | 744.87 | ||
| High | 89.94 | 455.43 | 757.55 | ||
| Low | 88.07 | 445.00 | 735.95 | ||
| Last | 89.76 | 450.37 | 744.50 | ||
| Change | +1.13 | -0.86 | +1.15 | ||
| % Change | +1.27% | -0.19% | +0.15% | ||
| Volume | 4,057,200 | 1,507,600 | 973,000 | ||
| 20-Day Average Volume | 7,529,130 | 1,345,780 | 873,520 | ||
| Previous Close | 88.63 | 451.23 | 743.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 90.89 | 479.24 | 825.31 | ||
| 20-Day Raw Stochastic | 28.71% | 7.17% | 4.11% | ||
| 20-Day Relative Strength | 53.58% | 40.89% | 16.67% | ||
| Weighted Alpha | +26.07 | +18.06 | -22.14 | ||
| Today's Opinion | 80% Buy | 8% Sell | 88% Sell | ||
| Previous Opinion | 80% Buy | 8% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 8% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.55% since 11/14/24 | -6.94% since 11/14/24 | -4.86% since 11/14/24 | ||
| Low | 86.08 on 11/19/24 | 445.00 on 11/21/24 | 735.95 on 11/21/24 | ||
| High | 91.99 on 11/15/24 | 479.93 on 11/15/24 | 783.10 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | +4.02% since 10/21/24 | -5.80% since 10/21/24 | -23.13% since 10/21/24 | ||
| Low | 85.60 on 10/22/24 | 445.00 on 11/21/24 | 735.95 on 11/21/24 | ||
| High | 98.90 on 11/11/24 | 519.88 on 11/08/24 | 972.74 on 10/22/24 | ||
| 3-Month | |||||
| %Chg | +19.47% since 08/21/24 | -7.35% since 08/21/24 | -37.19% since 08/21/24 | ||
| Low | 75.35 on 08/22/24 | 445.00 on 11/21/24 | 735.95 on 11/21/24 | ||
| High | 98.90 on 11/11/24 | 519.88 on 11/08/24 | 1,211.20 on 08/27/24 | ||
| 6-Month | |||||
| %Chg | +33.39% since 05/21/24 | +1.89% since 05/21/24 | -25.10% since 05/21/24 | ||
| Low | 62.07 on 05/31/24 | 435.57 on 05/30/24 | 735.95 on 11/21/24 | ||
| High | 98.90 on 11/11/24 | 519.88 on 11/08/24 | 1,211.20 on 08/27/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 110,456,552 | 116,204,808 | 81,686,728 | ||
| Shares Outstanding, K | 1,246,266 | 257,529 | 109,890 | ||
| Annual Sales | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 | ||
| Annual Net Income | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 | ||
| Last Quarter Sales | 7,545,000,000 | 2,771,900,000 | 3,720,700,000 | ||
| Last Quarter Net Income | 1,253,000,000 | 1,045,400,000 | 1,340,600,000 | ||
| 60-Month Beta | 0.17 | 0.39 | 0.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.02 on 11/06/24 | 4.38 on 11/04/24 | 12.46 on 10/31/24 | ||
| Latest Earnings Date | 11/06/24 | 11/04/24 | 10/31/24 | ||
| Most Recent Dividend | 0.770 on 09/13/24 | N/A | N/A | ||
| Next Ex-Dividends Date | 12/13/24 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 19.81 | 0.00 | 18.62 | ||